What is Cloopen Group Holding Limited's earnings per share (EPS)?

Cloopen Group Holding Limited (RAASY) reported diluted earnings per share of $-0.11 for fiscal year 2025. This represents a -83.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cloopen Group Holding Limited Financials

RAASY

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Cloopen Group Holding Limited (RAASY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RAASY FY2024 2026-05-08

Losses are shrinking through cost reset and balance-sheet monetization, while the core business remains cash consumptive.

Between FY2023 and FY2024, cash climbed to $87.7M even though free cash flow stayed negative at -$25.1M. The bridge was $63.1M of positive investing cash flow, so better liquidity came from balance-sheet reshaping, while the simultaneous narrowing of net loss and operating cash burn suggests a genuine reduction in cash losses rather than a paper-only improvement.

FY2024's much smaller operating loss reflects a leaner expense base, not renewed sales momentum: revenue slipped to $78.6M while SG&A fell to $12.9M and gross profit held roughly steady. With gross margin inching from 35.8% to 36.8%, most of the earnings improvement appears to come from cost removal rather than a fundamental change in demand.

The business still burns cash, but it is not heavily capital-intensive: capex was only $396K against free cash flow of -$25.1M, so cash use is coming from operations rather than from maintaining a large asset base. A current ratio of 2.8x and cash above current liabilities make near-term obligations look more manageable than the loss line alone would imply.

Financial Health Signals

Financial Profile 27/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Cloopen Group Holding Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Cloopen Group Holding Limited has an operating margin of -45.9%, meaning the company retains $-46 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -34.5% the prior year.

Growth

Cloopen Group Holding Limited's revenue declined 2.5% year-over-year, from $78.6M to $76.6M. This contraction results in a growth score of 29/100.

Leverage

Cloopen Group Holding Limited carries a low D/E ratio of 0.65, meaning only $0.65 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 89/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Cloopen Group Holding Limited's current ratio of 2.29 indicates adequate short-term liquidity, earning a score of 42/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Cloopen Group Holding Limited generated -$33.0M in operating cash flow, capex of $113K consumed most of it, leaving -$33.1M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Cloopen Group Holding Limited generates a -28.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 0/100. This is down from -13.3% the prior year.

Piotroski F-Score Weak

2/9

Cloopen Group Holding Limited passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.97x

For every $1 of reported earnings, Cloopen Group Holding Limited generates $0.97 in operating cash flow (-$33.0M OCF vs -$34.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$76.6M

YoY-2.5%

5Y CAGR-8.2%

Cloopen Group Holding Limited generated $76.6M in revenue in fiscal year 2025. This represents a decrease of 2.5% from the prior year.

EBITDA

-$34.4M

YoY-32.0%

Cloopen Group Holding Limited's EBITDA was -$34.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 32.0% from the prior year.

Net Income

-$34.2M

YoY-75.0%

Cloopen Group Holding Limited reported -$34.2M in net income in fiscal year 2025. This represents a decrease of 75.0% from the prior year.

EPS (Diluted)

$-0.11

YoY-83.3%

Cloopen Group Holding Limited earned $-0.11 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 83.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$33.1M

YoY-32.1%

Cloopen Group Holding Limited generated -$33.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 32.1% from the prior year.

Cash & Debt

$46.4M

YoY-47.1%

5Y CAGR+0.4%

Cloopen Group Holding Limited held $46.4M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

317M

Cloopen Group Holding Limited had 317M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

27.4%

YoY-9.4pp

5Y CAGR-12.6pp

Cloopen Group Holding Limited's gross margin was 27.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 9.4 percentage points from the prior year.

Operating Margin

-45.9%

YoY-11.4pp

5Y CAGR-9.0pp

Cloopen Group Holding Limited's operating margin was -45.9% in fiscal year 2025, reflecting core business profitability. This is down 11.4 percentage points from the prior year.

Net Margin

-44.7%

YoY-19.8pp

5Y CAGR+455.5pp

Cloopen Group Holding Limited's net profit margin was -44.7% in fiscal year 2025, showing the share of revenue converted to profit. This is down 19.8 percentage points from the prior year.

Return on Equity

-28.4%

YoY-15.2pp

Cloopen Group Holding Limited's ROE was -28.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 15.2 percentage points from the prior year.

Capital Allocation

R&D Spending

$19.9M

YoY-18.0%

5Y CAGR-5.6%

Cloopen Group Holding Limited invested $19.9M in research and development in fiscal year 2025. This represents a decrease of 18.0% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$113K

YoY-71.5%

5Y CAGR-33.0%

Cloopen Group Holding Limited invested $113K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 71.5% from the prior year.

RAASY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$76.6M-2.5%	$78.6M-2.3%	$80.4M-6.6%	$86.1M-27.1%	$118.1M+0.4%	$117.7M
Cost of Revenue	$55.6M+11.9%	$49.7M-3.7%	$51.6M-3.1%	$53.3M-29.4%	$75.4M+6.8%	$70.6M
Gross Profit	$21.0M-27.4%	$28.9M+0.2%	$28.8M-12.2%	$32.8M-23.1%	$42.7M-9.3%	$47.0M
R&D Expenses	$19.9M-18.0%	$24.2M-22.6%	$31.3M-33.8%	$47.3M+1.5%	$46.7M+76.0%	$26.5M
SG&A Expenses	$15.9M+23.4%	$12.9M-52.2%	$26.9M-41.8%	$46.3M-23.5%	$60.5M+91.7%	$31.6M
Operating Income	-$35.1M-29.6%	-$27.1M+55.9%	-$61.5M+56.5%	-$141.2M+1.3%	-$143.0M-229.5%	-$43.4M
Interest Expense	N/A	N/A	N/A	$62K+8.8%	$57K-97.4%	$2.2M
Income Tax	-$117K-172.1%	-$43K+45.6%	-$79K-58.0%	-$50K-102.9%	$1.7M+601.1%	$249K
Net Income	-$34.2M-75.0%	-$19.6M+66.1%	-$57.7M+59.2%	-$141.3M+0.3%	-$141.8M+75.9%	-$588.4M
EPS (Diluted)	$-0.11-83.3%	$-0.06+66.7%	$-0.18+59.1%	$-0.44+85.7%	$-3.08	N/A

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

RAASY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$196.8M-9.0%	$216.2M-13.9%	$251.3M-25.1%	$335.4M-29.4%	$474.9M+220.0%	$148.4M
Current Assets	$176.8M-10.1%	$196.7M-14.5%	$230.1M-26.1%	$311.4M-26.8%	$425.4M+215.8%	$134.7M
Cash & Equivalents	$46.4M-47.1%	$87.7M+64.7%	$53.2M-30.3%	$76.4M-25.8%	$103.0M+126.6%	$45.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$20.0M	N/A	$20.3M	N/A	$24.9M-29.0%	$35.1M
Goodwill	$7.8M+4.4%	$7.5M-2.7%	$7.7M-2.9%	$7.9M-58.7%	$19.1M	N/A
Total Liabilities	$77.8M+10.6%	$70.4M-15.2%	$83.0M-24.0%	$109.2M-3.5%	$113.1M-87.0%	$869.6M
Current Liabilities	$77.3M+10.9%	$69.7M-15.6%	$82.5M-23.5%	$107.9M-1.8%	$110.0M-7.6%	$119.0M
Long-Term Debt	N/A	N/A	N/A	N/A	$1.3M	N/A
Total Equity	$120.3M-18.3%	$147.2M-13.0%	$169.2M-25.4%	$226.6M-37.4%	$361.9M+150.2%	-$721.2M
Retained Earnings	-$1.5B-6.9%	-$1.4B+1.3%	-$1.4B-1.4%	-$1.4B-3.1%	-$1.3B-76.0%	-$753.2M

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Total Assets	$196.8M-9.0%	$216.2M-13.9%	$251.3M-25.1%	$335.4M-29.4%	$474.9M+220.0%	$148.4M
Current Assets	$176.8M-10.1%	$196.7M-14.5%	$230.1M-26.1%	$311.4M-26.8%	$425.4M+215.8%	$134.7M
Cash & Equivalents	$46.4M-47.1%	$87.7M+64.7%	$53.2M-30.3%	$76.4M-25.8%	$103.0M+126.6%	$45.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	$20.3M	N/A	$24.9M-29.0%	$35.1M
Goodwill	$7.8M+4.4%	$7.5M-2.7%	$7.7M-2.9%	$7.9M-58.7%	$19.1M	N/A
Total Liabilities	$77.8M+10.6%	$70.4M-15.2%	$83.0M-24.0%	$109.2M-3.5%	$113.1M-87.0%	$869.6M
Current Liabilities	$77.3M+10.9%	$69.7M-15.6%	$82.5M-23.5%	$107.9M-1.8%	$110.0M-7.6%	$119.0M
Long-Term Debt	N/A	N/A	N/A	N/A	$1.3M	N/A
Total Equity	$120.3M-18.3%	$147.2M-13.0%	$169.2M-25.4%	$226.6M-37.4%	$361.9M+150.2%	-$721.2M
Retained Earnings	-$1.5B-6.9%	-$1.4B+1.3%	-$1.4B-1.4%	-$1.4B-3.1%	-$1.3B-76.0%	-$753.2M

RAASY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$33.0M-33.8%	-$24.7M+66.0%	-$72.7M+11.6%	-$82.2M-120.1%	-$37.4M-8.8%	-$34.3M
Capital Expenditures	$113K-71.5%	$396K+247.4%	$114K-86.5%	$845K-27.2%	$1.2M+38.4%	$838K
Free Cash Flow	-$33.1M-32.1%	-$25.1M+65.5%	-$72.8M+12.4%	-$83.1M-115.7%	-$38.5M-9.5%	-$35.2M
Investing Cash Flow	-$11.5M-118.2%	$63.1M+27.4%	$49.5M-2.9%	$51.0M+117.9%	-$284.7M-1841.3%	-$14.7M
Financing Cash Flow	N/A	N/A	N/A	-$7.7M-102.0%	$383.6M+447.0%	$70.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

RAASY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	27.4%-9.4pp	36.8%+0.9pp	35.8%-2.3pp	38.1%+2.0pp	36.1%-3.9pp	40.0%
Operating Margin	-45.9%-11.4pp	-34.5%+42.0pp	-76.4%+87.7pp	-164.1%-43.0pp	-121.1%-84.2pp	-36.9%
Net Margin	-44.7%-19.8pp	-24.9%+46.9pp	-71.8%+92.5pp	-164.2%-44.1pp	-120.1%+380.1pp	-500.1%
Return on Equity	-28.4%-15.2pp	-13.3%+20.8pp	-34.1%+28.2pp	-62.4%-23.2pp	-39.2%	N/A
Return on Assets	-17.4%-8.3pp	-9.0%+13.9pp	-23.0%+19.2pp	-42.1%-12.3pp	-29.9%+366.6pp	-396.4%
Current Ratio	2.29-0.5	2.82+0.0	2.79-0.1	2.88-1.0	3.87+2.7	1.13
Debt-to-Equity	0.65+0.2	0.48-0.0	0.490.0	0.48+0.5	0.00+1.2	-1.21
FCF Margin	-43.3%-11.3pp	-31.9%+58.6pp	-90.5%+6.0pp	-96.5%-63.9pp	-32.6%-2.7pp	-29.9%

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	2.29-0.5	2.82+0.0	2.79-0.1	2.88-1.0	3.87+2.7	1.13
Debt-to-Equity	0.65+0.2	0.48-0.0	0.490.0	0.48+0.5	0.00+1.2	-1.21
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Namesilo Technologies Corp URLOF

$103.1M

Xtract One Technologies Inc. XTRAF

$92.4M

Argo Corp ARGHF

$64.6M

Ntg Clarity Ntwk NYWKF

$28.8M

Sylogist Ltd SYZLF

$56.8M

Frequently Asked Questions

What is Cloopen Group Holding Limited's annual revenue?

Cloopen Group Holding Limited (RAASY) reported $76.6M in total revenue for fiscal year 2025. This represents a -2.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cloopen Group Holding Limited's revenue growing?

Cloopen Group Holding Limited (RAASY) revenue declined by 2.5% year-over-year, from $78.6M to $76.6M in fiscal year 2025.

Is Cloopen Group Holding Limited profitable?

No, Cloopen Group Holding Limited (RAASY) reported a net income of -$34.2M in fiscal year 2025, with a net profit margin of -44.7%.

What is Cloopen Group Holding Limited's EBITDA?

Cloopen Group Holding Limited (RAASY) had EBITDA of -$34.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Cloopen Group Holding Limited's gross margin?

Cloopen Group Holding Limited (RAASY) had a gross margin of 27.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cloopen Group Holding Limited's operating margin?

Cloopen Group Holding Limited (RAASY) had an operating margin of -45.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cloopen Group Holding Limited's net profit margin?

Cloopen Group Holding Limited (RAASY) had a net profit margin of -44.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cloopen Group Holding Limited's return on equity (ROE)?

Cloopen Group Holding Limited (RAASY) has a return on equity of -28.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cloopen Group Holding Limited's free cash flow?

Cloopen Group Holding Limited (RAASY) generated -$33.1M in free cash flow during fiscal year 2025. This represents a -32.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cloopen Group Holding Limited's operating cash flow?

Cloopen Group Holding Limited (RAASY) generated -$33.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cloopen Group Holding Limited's total assets?

Cloopen Group Holding Limited (RAASY) had $196.8M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cloopen Group Holding Limited's capital expenditures?

Cloopen Group Holding Limited (RAASY) invested $113K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Cloopen Group Holding Limited spend on research and development?

Cloopen Group Holding Limited (RAASY) invested $19.9M in research and development during fiscal year 2025.

How many shares does Cloopen Group Holding Limited have outstanding?

Cloopen Group Holding Limited (RAASY) had 317M shares outstanding as of fiscal year 2025.

What is Cloopen Group Holding Limited's current ratio?

Cloopen Group Holding Limited (RAASY) had a current ratio of 2.29 as of fiscal year 2025, which is generally considered healthy.

What is Cloopen Group Holding Limited's debt-to-equity ratio?

Cloopen Group Holding Limited (RAASY) had a debt-to-equity ratio of 0.65 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cloopen Group Holding Limited's return on assets (ROA)?

Cloopen Group Holding Limited (RAASY) had a return on assets of -17.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cloopen Group Holding Limited's cash runway?

Based on fiscal year 2025 data, Cloopen Group Holding Limited (RAASY) had $46.4M in cash against an annual operating cash burn of $33.0M. This gives an estimated cash runway of approximately 17 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Cloopen Group Holding Limited's Piotroski F-Score?

Cloopen Group Holding Limited (RAASY) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cloopen Group Holding Limited's earnings high quality?

Cloopen Group Holding Limited (RAASY) has an earnings quality ratio of 0.97x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Cloopen Group Holding Limited?

Cloopen Group Holding Limited (RAASY) scores 27 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.